Suchergebnisse - "Zhao, Zhiting"

PubPharm (9)

1

Comparison of Efficacy and Safety of First-Line Treatment Options for Unresectable Stage III Non-Small Cell Lung Cancer : A Retrospective Analysis

enthalten in: International journal of clinical practice | 2024

von Zhao, L. | Zhao, Z. | Yan, X. | +6

2

Comparison of Efficacy and Safety of Second-Line Treatment Options for Advanced Small-Cell Lung Cancer : A Retrospective Analysis

enthalten in: Technology in cancer research & treatment | 2024

von Zhao, L. | Zhao, Z. | Yan, X. | +3

3

Comparison of efficacy and safety of first-line treatment options for unresectable stage III non-small cell lung cancer: a retrospective analysis

enthalten in: ResearchSquare.com | 2023

von Zhao, L. | Zhao, Z. | Yan, X. | +6

4

Comparison of efficacy and safety of first-line treatment options for unresectable stage III non-small cell lung cancer: a retrospective analysis

enthalten in: ResearchSquare.com | 2023

von Zhao, L. | Zhao, Z. | Yan, X. | +6

5

Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients : A retrospective study

enthalten in: Frontiers in oncology | 2022

von Zhao, Z. | Zhao, L. | Xia, G. | +7

6

Efficacy and Safety of PD-1 Immune Checkpoint Inhibitors in Locally Advanced and Advanced Non-Small-Cell Lung Cancer Patients with Chronic Infection

enthalten in: Oncology research and treatment | 2022

von Zhao, Z. | Hu, R. | Chen, Y. | +3

7

Efficacy and Safety of PD-1 Immune Checkpoint Inhibitors in Locally Advanced and Advanced NSCLC Patients With Chronic Viral Infection

enthalten in: ResearchSquare.com | 2021

von Zhao, Z. | Hu, R. | Chen, Y. | +4

8

Immune checkpoint inhibitors combined with chemotherapy/bevacizumab therapy for patients with advanced lung cancer and heavily treated with EGFR mutation : a retrospective analysis

enthalten in: Journal of thoracic disease | 2021

von Hu, R. | Zhao, Z. | Shi, Y. | +4

9

A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy

enthalten in: Frontiers in oncology | 2021

von Wu, R. | Yu, S. | Ye, J. | +4

1
[1]